XLI gives broad industrial exposure with upside potential, dividends, attractive valuation, strong growth names, and ...
The possibility of adding a new Big Tech customer helped lift an American chipmaker's stock on Friday, Nov. 28, 2025, while a ...
Now, let's consider whether a stock split may be in the cards for Lilly. As mentioned, the pharma giant has seen its stock ...
Standard Lithium Ltd. (NYSEA:SLI) is a company focused on developing lithium brine projects in the United States to produce ...
TipRanks on MSN
Luye Pharma Gains FDA Approval for New CNS Drug Trials
An update from Luye Pharma Group ( ($HK:2186) ) is now available. Luye Pharma Group Ltd. has received FDA clearance to initiate clinical trials in ...
Standard Lithium Ltd. recently reported financial results for the third quarter and nine months ended September 30, 2025, highlighting a US$6.12 million net loss for the quarter and a US$12.65 million ...
Detailed price information for Standard Lithium Ltd (SLI-A) from The Globe and Mail including charting and trades.
Albemarle surges with China lithium prices surged after Li Liangbin, chairman of major Chinese producer Ganfeng Lithium, said ...
Detailed price information for Standard Lithium Ltd (SLI-A) from The Globe and Mail including charting and trades.
Standard Lithium Ltd. engages in the testing and proving of the commercial viability of lithium extraction. Its projects include Arkansas Lithium, Lithium Brine Processing, and California Lithium. The ...
TipRanks on MSN
Standard Lithium Ltd. Reports Q3 2025 Financial Results
The latest update is out from Standard Lithium Ltd ( (TSE:SLI) ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results